Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
110.92
-0.42 (-0.38%)
Nov 21, 2024, 1:19 PM EST - Market open
Revvity Revenue
Revvity had revenue of $684.05M in the quarter ending September 29, 2024, with 1.98% growth. This brings the company's revenue in the last twelve months to $2.72B, down -2.66% year-over-year. In the year 2023, Revvity had annual revenue of $2.75B, down -16.95%.
Revenue (ttm)
$2.72B
Revenue Growth
-2.66%
P/S Ratio
5.04
Revenue / Employee
$236,657
Employees
11,500
Market Cap
13.50B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.75B | -561.25M | -16.95% |
Jan 1, 2023 | 3.31B | -515.99M | -13.48% |
Jan 2, 2022 | 3.83B | 1.16B | 43.73% |
Jan 3, 2021 | 2.66B | -220.44M | -7.64% |
Dec 29, 2019 | 2.88B | 105.68M | 3.80% |
Dec 30, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jan 1, 2017 | Pro | Pro | Pro |
Jan 3, 2016 | Pro | Pro | Pro |
Dec 28, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Fresenius Medical Care AG | 21.46B |
Tenet Healthcare | 20.97B |
Universal Health Services | 15.42B |
DaVita | 12.67B |
Avantor | 6.82B |
Moderna | 5.08B |
Incyte | 4.08B |
Genmab | 2.97B |
RVTY News
- 1 day ago - Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK - Business Wire
- 2 days ago - Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference - Business Wire
- 2 days ago - Scale Biosciences and Revvity's BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells - Business Wire
- 3 days ago - Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation - Business Wire
- 15 days ago - These Analysts Revise Their Forecasts On Revvity Following Q3 Results - Benzinga
- 17 days ago - Revitty (RVTY) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Revvity cuts 2024 revenue forecast amid biotech spending slowdown - Reuters
- 17 days ago - Revvity Announces Financial Results for the Third Quarter of 2024 - Business Wire